61 results on '"Dawson, Valina L."'
Search Results
2. Apoptotic cell death in disease—Current understanding of the NCCD 2023
3. Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
4. AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
5. Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation
6. Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis
7. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
8. AIF3 splicing switch triggers neurodegeneration
9. Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid
10. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
11. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
12. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
13. Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis
14. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
15. DISC1 regulates lactate metabolism in astrocytes: implications for psychiatric disorders
16. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
17. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
18. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
19. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases
20. Two approaches reveal a new paradigm of ‘switchable or genetics-influenced allele-specific DNA methylation’ with potential in human disease
21. Erratum: T cells from patients with Parkinson’s disease recognize α-synuclein peptides
22. T cells from patients with Parkinson’s disease recognize α-synuclein peptides
23. The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity
24. Neurotoxic reactive astrocytes are induced by activated microglia
25. Erratum: Corrigendum: Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss
26. Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder
27. The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
28. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss
29. Sulfhydration mediates neuroprotective actions of parkin
30. Ironing out tau's role in parkinsonism
31. Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death
32. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
33. Understanding microRNAs in neurodegeneration
34. Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
35. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis
36. Dynamic and redundant regulation of LRRK2 and LRRK1 expression
37. Kinase activity of mutant LRRK2 mediates neuronal toxicity
38. Taming the clot-buster tPA
39. Maiming mitochondria in familial ALS
40. Deadly Conversations: Nuclear-Mitochondrial Cross-Talk
41. Parkin-associated Parkinson’s disease
42. Role of AIF in caspase-dependent and caspase-independent cell death
43. New insights into Parkinson?s disease
44. Role for the Ubiquitin-Proteasome System in Parkinson's Disease and Other Neurodegenerative Brain Amyloidoses
45. Neuroprotective and neurorestorative strategies for Parkinson's disease
46. The genetics of Parkinson’s disease
47. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease
48. Identification by mRNA Differential Display of Two Up-regulated Genes as Candidate Mediators of AIDS Dementia
49. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
50. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.